NEW YORK (GenomeWeb News) – Roche today said that it will collaborate with SeqWright and the University of Miami Miller School of Medicine on identifying possible genetic variants associated with dilated cardiomyopathy.

The collaboration will employ NimbleGen's Sequence Capture Human Exome Arrays to enrich more than 180,000 exons from DNA samples taken from people with dilated cardiomyopathy, said Roche. SeqWright will sequence the enriched exons using 454 Life Sciences' Genome Sequencer FLX to detect SNPS, insertions, and deletions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.